Patrick Darken

Also affiliated with AstraZeneca (Spain), AstraZeneca (Canada)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation”.

Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation

The Journal of Allergy and Clinical Immunology In Practice(2024)10.1016/j.jaip.2024.06.037

N/A

0.208DataRank · unranked

3 citations

Alberto Papi, Richard Beasley, Elliot Israel, Reynold A. Panettieri, Frank C. Albers +7 more

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

UNC Libraries(2020)10.17615/md2j-3z93

N/A

0DataRank · unranked

0 citations

James F. Donohue, Sarvajna Dwivedi, Klaus F. Rabe, Patrick Darken, Chad Orevillo +11 more

Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

American Journal of Respiratory and Critical Care Medicine(2021)10.1164/rccm.202107-1663so

N/A

0DataRank · unranked

161 citations

Alvar Agusti, Bartolome R. Celli, MeiLan K. Han, James P. Allinson, Surya P. Bhatt +25 more